Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

Item
http://www.wikidata.org/entity/Q33852664
Unraveling the clonal hierarchy of somatic genomic aberrations.Genomic rearrangements in prostate cancer.Tumor clone dynamics in lethal prostate cancerERG expression in prostate cancer: biological relevance and clinical implication.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.ERG oncoprotein expression in prostate carcinoma patients of different ethnicities.PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.Significantly higher expression levels of androgen receptor are associated with erythroblastosis virus E26 oncogene related gene positive prostate cancer.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature
P2860

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

Item
http://www.wikidata.org/entity/Q33852664
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@ast
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@en
type
label
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@ast
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@en
prefLabel
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@ast
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
@en
P2093
P2860
P304
P31
P356
10.1158/1055-9965.EPI-13-1180
P433
P478
P50
P577
P698
P921
P932